Biocause Pharmaceutical to Increase Shares in Domestic Stock Market

被引：0

作者：

机构：

来源：

China Chemical Reporter | 2008年 / 19卷 / 03期

关键词：

Biocause Pharmaceutical to Increase Shares in Domestic Stock Market;

D O I：

暂无

中图分类号：

F426.72 [];

学科分类号：

0202 ; 020205 ;

摘要：

Hubei Biocause Pharmaceutical Co.,Ltd.(Biocause Pharmaceutical,SZ:000627) announced on January 3rd its scheme for the non-publicoffering has been approved by China Securities Regulatory Commission.The company plans to issue up to 82 million domestic shares,at a

引用

页码：10 / 10

页数：1